A Dose Optimization/Expansion Study of SAR445877 in Adult Chinese Participants With Advanced Gastric or Gastroesophageal Junction Cancer

NCT07692204 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Oesophageal Carcinoma

Interventions

DRUG: SAR445877

Sponsor

Sanofi